(A) Public human RNA-seq dataset (n=8) (GSE114007) showing CBFB mRNA expression level in Normal and OA patient cartilage. (B) Public human methyl-seq dataset (n=5) (GSE63695) showing methylation at the CBFB promoter region (cg13500388 and cg00487831) in Normal and OA hip tissue. Statistical significance was assessed using Student’s t-test. Values were considered statistically significant at p<0.05. (C) Western blot to examine Cbfβ protein levels in the hip articular cartilage of 3.5-month-old male oil injected Cbfbf/f;Col2a1-CreERT and TMX injected Cbfbf/f;Col2a1-CreERT, and 4-month-old male TMX injected Cbfbf/f;Acan-CreERT mice (n=3). (D) Quantification of (C). (E) X-ray of 3.5-month-old TMX injected female Cbfbf/f mouse hip, shoulder, and knee joint (n=15). (F) X-ray of 3.5-month-old oil injected female Cbfbf/f;Col2a1-CreERT mouse hip, shoulder, and knee joint (n=15). (G) X-ray of 3.5-month-old TMX injected female Cbfbf/f;Col2a1-CreERT mouse hip, shoulder, and knee joint (n=12). (H) X-ray of 3.5-month-old TMX injected male Cbfbf/f;Col2a1-CreERT mouse hip, shoulder, and knee joint. Green arrow: osteophytes in shoulder; yellow arrow: hip joint space; white arrow: hyperosteogeny in knee. (I) X-ray image of hips and knee joints of 9-month-old female Cbfbf/f;Col2a1-CreERT mice with oil injection and Cbfbf/f;Col2a1-CreERT mice with TMX injection (n=9). Red arrow 1,2,3: worn articular cartilage; Red arrow 4,5: osteophytes (spurs); Red arrow head: narrow joint space; Yellow arrow head: healthy hip joint space.
Figure 1—source data 1. Labeled raw western blot data for Figure 1C (anti-Cbfβ and anti-Gapdh).
Figure 1—source data 2. Unlabeled raw western blot data for Figure 1C (anti-Cbfβ and anti-Gapdh).